当前位置: X-MOL 学术Nat. Rev. Drug. Disc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Ida Sim
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2018-10-01 , DOI: 10.1038/nrd.2018.178


Ida Sim

Ida Sim, Published online: 01 October 2018; doi:10.1038/nrd.2018.178

Ida Sim, Vivli co-founder and UCSF informatician, discusses the need for a neutral broker platform that can facilitate access to and analysis of industry and academic patient-level clinical trial data.


中文翻译:

艾达·辛

艾达·辛

艾达·辛(Ida Sim),在线发布:2018年10月1日; doi:10.1038 / nrd.2018.178

Vivli联合创始人兼UCSF信息学家Ida Sim讨论了对中立经纪人平台的需求,该平台可以促进对行业和学术患者水平的临床试验数据的访问和分析。
更新日期:2018-10-01
down
wechat
bug